A meta-analysis of biochemotherapy (BCT) for the treatment of metastatic malignant melanoma (MM).

被引：0
|
作者：
El-Maraghi, R
Verma, S
Charette, M
Markman, B
Quirt, I
机构：
[1] Ottawa Reg Canc Ctr, Ottawa, ON K1Y 4K7, Canada
[2] McMaster Univ, Hamilton, ON, Canada
[3] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7529
引用
收藏
页码：717S / 717S
页数：1
相关论文
共 50 条
  • [1] Biochemotherapy versus chemotherapy for metastatic malignant melanoma: A meta-analysis of the randomised trials
    Ives, N. J.
    Stowe, R. L.
    Lorigan, P.
    Wheatley, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Phase I study of ipilimumab (IPI) with biochemotherapy (BCT) for chemonaive patients with metastatic melanoma (MM).
    Amaria, Rodabe Navroze
    Bassett, Roland L.
    Simpson, Lauren
    Delaney, Frances
    Hwu, Patrick
    Kim, Kevin
    Hwu, Wen-Jen
    Patel, Sapna Pradyuman
    Glitza, Isabella Claudia
    Davies, Michael A.
    Woodman, Scott Eric
    Yee, Cassian
    Bedikian, Agop Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] Biochemotherapy for the treatment of metastatic malignant melanoma: A systematic review
    Hamm, Caroline
    Verma, Shailendra
    Petrella, Teresa
    Bak, Kate
    Charette, Manya
    CANCER TREATMENT REVIEWS, 2008, 34 (02) : 145 - 156
  • [4] Use of sequential biochemotherapy (BCT) in patients (pts) with malignant melanoma (Mm): Results of a phase II trial
    Bojanapally, P. R.
    Rusciano, V.
    Wiernik, P.
    Dutcher, J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (05) : 810 - 810
  • [5] Biochemotherapy for the treatment of metastatic malignant melanoma: a clinical practice guideline
    Verma, S.
    Petrella, T.
    Hamm, C.
    Bak, K.
    Charette, M.
    CURRENT ONCOLOGY, 2008, 15 (02) : 85 - 89
  • [6] A phase II study of biochemotherapy for the treatment of metastatic malignant melanoma
    Gibbs, P
    Iannucci, A
    Becker, M
    Allen, J
    O'Driscoll, M
    McDowell, K
    Williams, P
    Rosse, P
    Murphy, J
    Gonzalez, R
    MELANOMA RESEARCH, 2000, 10 (02) : 171 - 179
  • [7] Phase I study of nab-paclitaxel (NP) in combination with biochemotherapy (BCT) in patients (pts) with metastatic melanoma (MM)
    Alrwas, Anas
    Papadopoulos, Nicholas E.
    Cain, Suzanne
    Patel, Sapna Pradyuman
    Kim, Kevin B.
    Deburr, Tawania L.
    Bassett, Roland
    Hwu, Wen-Jen
    Bedikian, Agop Y.
    Davies, Michael A.
    Woodman, Scott Eric
    Hwu, Patrick
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [8] On the effect of biochemotherapy in metastatic malignant melanoma:: An immunopathological evaluation
    Håkansson, A
    Håkansson, L
    Gustafsson, B
    Krysander, L
    Rettrup, B
    Ruiter, D
    Bernsen, MR
    MELANOMA RESEARCH, 2003, 13 (04) : 401 - 407
  • [9] Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma: A meta-analysis of 18 trials involving 2,621 patients
    Ives, Natalie J.
    Stowe, Rebecca L.
    Lorigan, Paul
    Wheatley, Keith
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (34) : 5426 - 5434
  • [10] Biochemotherapy in the treatment of metastatic melanoma in selected patients
    Gonzalez Astorga, Beatriz
    Jimenez Rubiano, Berta
    Delgado Perez, Juan Ramon
    Valdivia Bautista, Javier
    Sanchez Toro, Carmen
    Gonzalez Flores, Encarnacion
    Luque Caro, Raquel
    Castellon Rubio, Victoria
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (06): : 382 - 386
12345